MAGE-A4-响应性血细胞促进非小细胞肺癌的发展
bioRxiv : the preprint server for biology
|July 29, 2024
概括
黑色素瘤抗原-A4 (MAGE-A4) 通过招募产生IgA的血细胞来促进非小细胞肺癌 (NSCLC). 针对这些MAGE-A4响应性血细胞 (MARP) 降低了瘤生长,增强了抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 适应性免疫对于消除癌细胞至关重要,但瘤具有内在因素,可以损害这种反应.
- 黑色素瘤抗原-A4 (MAGE-A4),一种癌症丸抗原,与非小细胞肺癌 (NSCLC) 的生存率低下有关,但其在调节抗瘤免疫力方面的确切作用尚未完全理解.
- 人类NSCLC中MAGE-A4表达与瘤抑制剂PTEN的丧失密切相关.
研究的目的:
- 在NSCLC的背景下,研究MAGE-A4在改变抗瘤免疫力的作用.
- 阐明MAGE-A4影响瘤微环境和免疫细胞群的机制.
主要方法:
- 人类MAGE-A4的构成表达和Pten的损失被诱导到小鼠气道上皮细胞中,以建模NSCLC.
- 免疫组织化学和流细胞测量用于分析小鼠模型和人类NSCLC组织中的免疫细胞群 (CD138+,CXCR4+,IGA+,CD163+,CD206+).
- 评估了取消MAGE-A4响应性血细胞 (MARP) 对瘤负担,T细胞透/激活和巨细胞群的影响.
主要成果:
- 在小鼠中,MAGE-A4表达与Pten损失相结合导致转移性腺癌,富含CD138+ CXCR4+ IgA+ 血细胞.
- 人类表达MAGE-A4的NSCLC在瘤周围表现出CD138+IgA+血细胞密度增加.
- 在小鼠中,MARP的废除减少了瘤负担,增强了T细胞反应,并减少了亲瘤原生的巨细胞.
结论:
- MAGE-A4有助于NSCLC瘤发生,至少部分是通过在肺微环境中招募和保留IgA+ MARP.
- 这些发现突出了由MAGE-A4和IgA+等离子体细胞介导的NSCLC中免疫逃避的新机制.
- 向MARP代表了NSCLC的潜在治疗策略,旨在恢复抗瘤免疫力.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


